Share this page

 DUHUNTX — 2467454

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2467454

Type(s)

Standard Characters

Category

Trademark

CIPO Status

FORMALIZED

TM5 status

LIVE/APPLICATION/ Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Filed

2026-04-07

Applicant

Skyhawk Therapeutics, Inc.
180 3rd Avenue, Sixth Floor
Waltham, MA 02451
UNITED STATES OF AMERICA

Agent

BCF S.E.N.C.R.L./BCF LLP
1100, boul. René-Lévesque Ouest
25e Étage
Montréal
QUÉBEC H3B5C9

Documents

View documents

Index headings

  • DUHUNTX

Goods (Nice class & Statement)

5
(1) Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington's Disease.

Claims

  • Priority Filing Date: March 20, 2026, Country or Office: UNITED STATES OF AMERICA, Application No. 99715547 in association with the same kind of goods

Action History

Actions
Action Action date Due date Comments
Filed 2026-04-07
Created 2026-04-07
Formalized 2026-04-07
Pre-Assessment Letter Sent 2026-04-23 Goods or Services Not Acceptable
Report a problem on this page
Date modified: